Isradipine, >=98% (HPLC), solid

Isradipine, >=98% (HPLC), solid

Application

Isradipine has been used to explore neuroprotective activity.

Biochem/physiol Actions

L-type calcium channel blocker (also referred to as dihydropyridine-type calcium channel blocker); antihypertensive.

Isradipineis considered as an active calcium channel blocker, used to treat hypertension.

Features and Benefits

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Other Notes

Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. I6658.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour InChI key InChI Manufacturer Further Info Form Assay Price Quantity
3573412 Isradipine, >=98% (HPLC), solid yellow HMJIYCCIJYRONP-UHFFFAOYSA-N 1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3 SIGMA-ALDRICH
£888.64 (exc VAT) per 25MG
-
+
3573413 Isradipine, >=98% (HPLC), solid yellow HMJIYCCIJYRONP-UHFFFAOYSA-N 1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3 SIGMA-ALDRICH
£236.79 (exc VAT) per 5MG
-
+